Coralie Reger de Moura

Discoidin domain receptors: A promising target in melanoma

Coralie Reger de Moura, Maxime Battistella, Anjum Sohail et al. · Pigment Cell & Melanoma Research · 2019 · 33 citations

Phase I–II Open-Label Multicenter Study of Palbociclib + Vemurafenib in <i>BRAF</i> V600MUT Metastatic Melanoma Patients: Uncovering CHEK2 as a Major Response Mechanism

Baptiste Louveau, Matthieu Resche‐Rigon, Thierry Lesimple et al. · Clinical Cancer Research · 2021 · 18 citations · Full text

A targeted genomic alteration analysis predicts survival of melanoma patients under BRAF inhibitors

Baptiste Louveau, Julie Delyon, Coralie Reger de Moura et al. · Oncotarget · 2019 · 17 citations · Full text

Intermittent Versus Continuous Dosing of MAPK Inhibitors in the Treatment of BRAF-Mutated Melanoma

Coralie Reger de Moura, Laëtitia Vercellino, Fanélie Jouenne et al. · Translational Oncology · 2019 · 15 citations · Full text

CD147 Promotes Tumor Lymphangiogenesis in Melanoma via PROX-1

Coralie Reger de Moura, Alexandra Landras, Farah Khayati et al. · Cancers · 2021 · 13 citations · Full text

Cancer Immunosurveillance, Angiogenesis, Endothelial Cells +11